former
fullterm
infant
without
medic
histori
present
emerg
depart
ed
day
ill
compris
cough
nasal
congest
fever
max
physic
examin
child
alert
interact
vital
sign
signific
tachypnea
normal
oxygen
satur
measur
puls
oximetri
respiratori
examin
reveal
child
moder
respiratori
distress
subcost
intercost
retract
coars
breath
sound
expiratori
wheez
audibl
lung
field
nasal
wash
sent
rapid
viral
screen
come
back
posit
respiratori
syncyti
viru
rsv
bronchodil
trial
ineffect
trial
racem
epinephrin
although
child
respiratori
distress
abl
maintain
hydrat
possibl
manag
home
howev
ed
physician
uncomfort
discharg
home
therefor
physician
decid
obtain
blood
sampl
infant
analyz
peripher
blood
leukocyt
global
gene
express
mean
rna
microarray
abstract
modern
pediatr
emerg
medicin
biomarkerbas
assay
enabl
quick
bedsid
diagnost
subsequ
diseas
manag
valuabl
grow
need
novel
diseasespecif
biomark
improv
outcom
pediatr
infecti
diseas
commonli
encount
emerg
depart
ed
viral
respiratori
infect
central
nervou
system
infect
sepsi
septic
shock
acut
diseas
state
frequent
encount
ed
review
describ
host
novel
biomark
includ
divers
set
cytokin
chemokin
nitric
oxidebas
metabolit
base
diseas
pathophysiolog
rational
provid
molecularor
biomarkerbas
approach
ed
throughout
review
emphasi
place
diagnost
rapid
relat
directli
timeli
qualiti
care
busi
ed
biomark
becom
clinic
avail
rapid
ed
set
bedsid
pointofcar
assay
qualiti
care
enhanc
mean
diagnost
also
prognost
sever
ill
rna
chip
base
rna
express
profil
set
gene
overexpress
vs
underexpress
predict
patient
get
sicker
rsv
bronchiol
henc
physician
decid
safest
cours
would
observ
infant
hour
ed
provid
uniqu
clinic
venu
develop
test
implement
novel
biomark
costeffect
rapid
abil
manag
acut
well
chronic
diseas
process
acut
exacerb
loss
health
insur
coverag
follow
econom
recess
unit
state
turn
led
increas
ed
util
given
increas
number
pediatr
patient
seen
unmet
need
viabl
rapid
biomark
variou
infecti
diseas
state
commonli
encount
ed
use
biomark
crucial
diagnost
prognost
perspect
earli
accur
detect
infecti
diseas
state
ed
set
potenti
impact
morbid
mortal
way
improv
diseas
manag
acut
viral
bronchiol
influenzalik
ill
ili
season
nonseason
virus
mening
enceph
sepsi
septic
shock
frequent
encount
infecti
diseas
state
children
present
ed
use
diseas
state
exampl
review
review
hope
speak
rational
current
state
biomarkerbas
analys
abovement
infecti
diseas
state
also
make
case
biomarkerbas
test
found
use
pediatr
ed
set
develop
pointofcar
assay
would
logic
next
step
acut
bronchiol
ili
major
respiratori
infect
commonli
encount
pediatr
ed
respiratori
syncyti
viru
common
caus
lower
respiratori
tract
infect
particularli
children
includ
bronchiol
pneumonia
broad
spectrum
diseas
sever
bronchiol
lead
caus
hospit
infant
unit
state
associ
hospit
cost
excess
million
per
year
also
respons
frequent
ed
visit
pandem
like
novel
swineorigin
influenza
viru
pose
signific
challeng
increas
transmiss
rel
season
influenza
sever
diseas
patient
medic
comorbid
difficulti
predict
children
viral
respiratori
symptom
risk
influenza
complic
given
immens
diseas
burden
respiratori
infect
develop
rapid
diagnost
prognost
tool
press
need
evalu
acut
ill
children
respiratori
infect
ed
risk
stratif
use
biomark
might
augment
clinic
decis
make
thu
improv
clinic
outcom
one
propos
mechan
rsv
pathophysiolog
reli
tolllik
receptor
function
tolllik
receptor
along
coreceptor
activ
bacteri
lipopolysaccharid
rsvspecif
fprotein
elicit
similar
respons
respons
significantli
weaker
lipopolysaccharid
respons
anoth
cofactor
polypeptid
believ
play
import
role
pathway
describ
relationship
still
investig
lipopolysaccharid
antagonist
analog
lower
lp
mandat
activ
also
lower
rsv
fproteinmand
activ
measur
rsv
fprotein
level
activ
level
offer
potenti
novel
biomark
system
pediatr
domain
prognost
purpos
serum
vitamin
level
anoth
biomark
research
acut
bronchiol
serum
vitamin
level
shown
vari
directli
immunoglobulin
g
level
invers
immunoglobulin
e
level
acut
stage
bronchiol
data
recent
clinic
trial
show
serum
vitamin
level
significantli
lower
children
acutephas
bronchiol
compar
healthi
control
microarraybas
wholegenom
express
array
also
use
ed
determin
correl
sever
rsv
bronchiol
recent
show
system
activ
interferon
signal
network
acut
rsv
infect
children
present
ed
also
show
biosignatur
effect
discrimin
patient
acut
rsv
bronchiol
healthi
agematch
control
gene
transcript
protein
product
could
promis
biomark
acut
rsv
bronchiol
futur
prospect
studi
case
vignett
begin
articl
describ
one
hypothet
situat
microarraybas
biomark
might
benefit
clinic
decis
make
dnaor
rnabas
diagnost
prognost
test
costeffect
rapid
enough
clinic
effect
busi
ed
set
irrespect
studi
invas
natur
blood
collect
determin
serum
level
put
biomark
acut
bronchiol
potenti
deterr
use
ed
set
serum
concentr
shown
potenti
biomark
diseas
sever
pandem
influenza
type
promin
cytokin
immun
respons
play
critic
role
acutephas
respons
fever
also
relev
sever
pathogen
inflammatori
state
serum
concentr
vari
directli
sepsi
sever
onset
type
sever
acut
respiratori
syndrom
serum
pandem
significantli
higher
patient
requir
critic
care
support
compar
howev
affect
diseas
outcom
suggest
show
potenti
biomark
diseas
sever
therapeut
agent
mention
bronchiol
biomark
serum
level
would
requir
blood
sampl
thu
nonid
pediatr
ed
influenza
viru
infect
epitheli
cell
macrophag
lymphocyt
cell
releas
complex
seri
cytokin
chemokin
attempt
overcom
viral
replic
diseas
progress
nitric
oxid
key
mediat
airway
inflamm
also
releas
unclear
increas
activ
marker
clinic
diseas
marker
innat
antivir
respons
associ
significantli
uniqu
respiratori
viru
infect
murin
model
rsv
instanc
product
lung
appear
associ
viral
clearanc
lung
diseas
induc
synthas
activ
product
associ
enhanc
clearanc
rsv
yet
also
associ
airway
inflammatori
chang
airway
dysfunct
murin
studi
experiment
influenza
atrigg
pneumonia
excess
biosynthesi
measur
metabolit
nitrat
nitrit
collect
refer
nox
demonstr
lung
suggest
metabolit
may
marker
influenzamedi
diseas
respiratori
tract
human
produc
upper
lower
respiratori
tract
detect
exhal
air
healthi
individu
increas
level
subject
pulmonari
diseas
includ
asthma
bronchiectasi
upper
respiratori
infect
aqueou
solut
rapidli
convert
distinct
oxid
nitrogen
may
thu
potenti
biomark
diseas
sever
acut
ill
patient
present
ili
ed
novel
pandem
collect
nasal
wash
specimen
children
ili
ed
measur
nox
concentr
highperform
liquid
chromatographi
overal
data
suggest
concentr
noderiv
nitrat
nasal
secret
children
ed
may
relat
type
viral
pathogen
caus
ili
rsv
subtyp
bassoci
ili
higher
nasal
wash
nitrat
compar
virus
combin
p
ongo
studi
determin
predict
potenti
put
biomark
import
diseas
outcom
sicker
patient
exhal
also
studi
put
biomark
respiratori
infect
caus
influenza
rhinoviru
viral
pathogen
data
equivoc
conflict
data
may
simpli
reflect
technic
issu
measur
exhal
methodolog
cumbersom
achiev
pediatr
popul
either
inpati
ed
newer
nioxmino
aerocrin
morrisvil
nc
handheld
detector
proven
reliabl
older
stationari
chemiluminesc
analyz
ecomed
eco
medic
duernten
switzerland
portabl
may
make
easier
handl
ed
set
focus
stabl
metabolit
nasal
secret
patient
ili
ed
may
still
better
approach
readi
access
futur
studi
need
establish
correl
nasal
secret
nox
exhal
ilityp
diseas
process
ed
major
benefit
work
respiratori
tractbas
biomark
either
exhal
breath
via
biochem
analys
nasal
secret
independ
blood
collect
ed
mening
lifethreaten
infect
central
nervou
system
cn
bacteri
mening
particular
remain
import
public
health
problem
worldwid
sever
studi
confirm
devast
neurolog
sequela
may
result
case
vari
sever
like
pass
ed
earli
cerebrospin
fluid
csf
base
biomark
need
may
abl
predict
sever
apolipoprotein
e
apo
glycosyl
protein
far
rang
function
apolipoprotein
e
tradit
studi
lipid
metabol
vascular
diseas
emerg
bodi
evid
suggest
play
key
role
immun
respons
includ
modul
inflamm
oxid
thu
apo
intrigu
candid
biomark
csf
infect
caus
inflamm
bacteri
mening
cerebrospin
fluid
apo
level
significantli
increas
patient
bacteri
mening
compar
healthi
control
sensit
specif
csf
valu
vs
sensit
specif
serum
although
collect
csf
serum
invas
high
measur
valid
replic
consist
apo
potenti
promin
diagnost
biomark
bacteri
mening
nitric
oxid
metabolit
csf
may
repres
anoth
set
biomark
studi
shown
patient
admit
hospit
bacteri
mening
influenzaassoci
encephalopathi
higher
level
csf
nox
compar
control
anoth
studi
patient
rsv
infect
cn
symptom
enceph
encephalopathi
seizur
found
higher
concentr
csf
nox
compar
influenzaposit
encephalopathi
without
mening
neither
studi
set
ed
analyz
csf
nox
mening
differ
pathogen
set
use
rapid
highperform
liquid
chromatographybas
assay
detect
metabolit
csf
ed
set
may
add
current
armamentarium
help
earli
diagnosi
differ
form
mening
may
predict
diseas
sever
detect
csf
nox
rapid
edbas
assay
may
particularli
help
case
difficult
interpret
case
csf
pleocytosi
ad
inform
may
help
guid
manag
ultim
result
better
diseas
outcom
sepsi
defin
system
respons
infect
half
patient
encount
progress
septic
shock
character
refractori
hypotens
multipleorgan
failur
sever
sepsi
septic
shock
associ
mortal
rate
high
sever
hemodynam
implic
macrovascular
microvascular
failur
central
role
maintain
microcircul
highlight
sepsi
septic
shock
state
microcircul
sustain
insult
sever
studi
implic
overproduct
caus
decompens
state
sepsi
septic
shock
system
inflammatori
respons
syndrom
intens
care
set
associ
increas
plasma
level
nox
measur
plasma
urinari
nox
reveal
elev
patient
sepsi
septic
shock
may
caus
elev
innat
immun
respons
infect
inflamm
particularli
sepsi
shock
respons
associ
increas
activ
induc
synthas
thu
releas
urinari
nox
primarili
nitrat
reflect
product
use
sepsi
shock
expos
kidney
ischem
injuri
reflect
low
level
urinari
nox
excret
like
caus
low
endogen
gener
convers
filter
nitrat
nitrit
reabsorb
renal
tubul
high
level
urin
secondari
reduc
renal
reabsorpt
may
reflect
acut
renal
failur
concomit
sepsissept
shock
although
directli
indirectli
convers
peroxynitrit
bactericid
excess
level
counterproduct
evidenc
refractori
vasodil
hypotens
decreas
tissu
perfus
irrespect
mechan
level
metabolit
downstream
effector
innat
immun
activ
lend
potenti
biomark
sepsi
may
particularli
use
ed
concentr
nox
plasma
urin
may
predict
import
inpati
clinic
outcom
need
hospit
level
support
intens
care
vs
regular
floor
mortal
neonat
sepsi
subset
sepsi
septic
shock
signific
annual
caus
morbid
mortal
infect
account
third
neonat
death
occur
global
neonat
infect
includ
sepsi
pneumonia
mening
account
estim
million
neonat
death
worldwid
everi
year
clinic
find
neonat
sepsi
nonspecif
thu
complic
diagnosi
result
overtreat
earli
diagnosticscreen
measur
blood
complet
blood
count
creactiv
protein
tumor
necrosi
factor
granulocytemacrophagecolonystimul
factor
procalcitonin
pct
name
studi
newborn
pct
shown
limit
promis
biomark
realm
consist
fallen
short
specif
procalcitonin
level
often
increas
sever
noninfecti
diseas
condit
render
nonspecif
sepsi
although
pct
level
help
manag
sepsi
diagnost
link
unclear
addit
prohibit
cost
depend
blood
draw
base
therapeut
decis
make
major
detractor
ed
set
biomark
entir
satisfactori
sepsi
septic
shock
owe
lack
sensit
specif
diagnost
economi
howev
urinari
biomark
may
provid
novel
approach
obtain
noninvas
bag
urinari
specimen
much
practic
less
cumbersom
obtain
blood
urinari
analysi
nox
level
may
particularli
use
identifi
neonat
high
risk
seriou
bacteri
infect
result
sepsi
shock
tertiari
ed
inpati
set
nontertiari
care
commun
set
obviou
valu
obtain
noninvas
specimen
ed
determin
level
biomark
diseas
entiti
requir
develop
valid
clinic
usag
rel
simpl
rapid
costeffect
techniqu
may
sampl
multipl
bodi
fluid
plasma
urin
nasal
secret
csf
summar
figur
regard
hypothet
clinic
vignett
outset
instead
invas
blood
specimen
nasal
wash
initi
obtain
rapid
viral
diagnosi
also
use
obtain
host
cellular
materi
rna
express
profil
done
cellular
materi
assum
rel
rapid
turnaround
gene
express
signatur
might
correl
sever
respiratori
ill
inform
thu
obtain
might
use
make
patient
disposit
concentr
biomark
interest
might
also
reliabl
obtain
rapid
manner
ed
pointofcar
test
variou
biolog
sampl
adapt
valid
pointofcar
test
figur
hypothet
biomarkerbas
approach
commonli
encount
infect
pediatr
ed
put
biomark
interest
respect
pediatr
infect
diseas
shown
last
column
differ
specimen
blood
nasal
wash
exhal
air
urin
csf
collect
describ
detail
text
abbrevi
cn
central
nervou
system
csf
cerebrospin
fluid
er
emerg
room
ili
influenzalik
ill
nitric
oxid
nox
nitric
oxid
metabolit
rsv
respiratori
syncyti
viru
assist
industri
partner
enabl
inexpens
screen
capac
dipstick
pointofcar
platform
aid
treatment
decis
certain
global
health
implic
go
far
beyond
ed
analysi
nox
shown
promis
dipstick
domain
particularli
salivari
nox
level
detect
use
griess
reaction
dipstick
could
develop
rapid
urinari
analysi
highimpact
implic
divers
set
rang
busi
ed
rural
communitytyp
set
littl
access
laboratori
clinic
analyt
system
